| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO | See Remarks | SVP & Chief Financial Officer +1 more
3 companies
David D O'Toole is CFO at RCEL, with reported holdings spanning 3 companies. David D O'Toole's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $2.9M at current prices.
Our model assigns David D O'Toole a middling insider score of 51/100, based on 19 past trades. Over a 12-month horizon, 31.3% of those trades were profitable, with an average 12-month return of -14.0%.
David D O'Toole's largest disclosed position is in RCEL as CFO, worth about $2.3M. Net of sales, the RCEL filings show accumulation of 31,675 shares.
David D O'Toole has 38 Form 4 filings on record from January 2015 to June 2026, across 3 companies: CFO at AVITA Medical (RCEL), 2023–2026; CFO at AVITA Medical (AVHHL), 2026; Director at Soleno Therapeutics (SLNO), 2015–2017.
The 53 reported transactions were 37 open-market purchases, 9 option or other derivative awards and 7 stock awards.
Counted by filing, the open-market trades come to 26 purchases worth about $442K and no sales.
The largest open-market purchase was 5,000 shares of RCEL at an average $17.93 on August 15, 2023, about $90K. Twelve months later RCEL was down 49%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2026 | RCEL Avita Medical, Inc. | CFO | Buy | 2,000 | $4.26 | $8,520.00 | +1.4% | +128.0% | - | |
| May 19, 2026 | RCEL Avita Medical, Inc. | CFO | Buy | 2,000 | $4.24 | $8,480.00 | +1.4% | +88.1% | - | |
| Mar 11, 2026 | AVHHL Avita Medical, Inc. | CFO | Buy | 1,800 | $4.78 | $8,604.00 | +1.3% | - | - | |
| Feb 19, 2026 | RCEL Avita Medical, Inc. | CFO | Buy | 3,000 | $4.15 | $12,450.00 | +2.2% | -1.4% | - | |
| Aug 26, 2025 | RCEL Avita Medical, Inc. | CFO | Buy | 2,000 | $4.52 | $9,040.00 | +6.7% | -17.8% | +132.2% | |
| Aug 12, 2025 | RCEL Avita Medical, Inc. | CFO | Buy | 2,000 | $4.81 | $9,620.00 | +7.2% | -28.1% | +47.1% | |
| Feb 20, 2025 | RCEL Avita Medical, Inc. | CFO | Buy | 1,000 | $9.90 | $9,900.00 | +4.0% | -34.5% | -51.9% | |
| Feb 19, 2025 | RCEL Avita Medical, Inc. | CFO | Buy | 1,000 | $10.25 | $10,250.00 | +4.2% | -34.4% | -57.1% | |
| Dec 5, 2024 | RCEL Avita Medical, Inc. | CFO | Buy | 975 | $12.46 | $12,151.75 | +4.3% | -31.5% | -71.9% | |
| May 30, 2024 | RCEL Avita Medical, Inc. | CFO | Buy | 1,000 | $8.90 | $8,900.00 | +5.3% | -2.0% | -39.6% |